Molecular cloning and expression analysis of the GNAS gene in pig and porcine fibroblast cells

Genetics and Molecular Research

Volumn 13, Issue 3, 2014, Pages 5463-5473

  Peng, J ^a   Li, Y L ^a   Shen, Y F ^a   Wang, Y ^b   Xu, N Y ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b TAIYUAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Apoptosis; Guanine nucleotide binding protein; Pig; Thyroid gland

Indexed keywords

CASPASE 3; FAS ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MESSENGER RNA; PROTEIN BCL 2; SMALL INTERFERING RNA; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ABDOMINAL FAT; ADULT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO; FIBROBLAST; GENE EXPRESSION; GNAS GENE; HEART; HYPOPHYSIS; HYPOTHALAMUS; KIDNEY; LARGE INTESTINE; LEG; LIVER; LONGISSIMUS DORSI MUSCLE; LUNG; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; SKELETAL MUSCLE; SMALL INTESTINE; STOMACH; SUBCUTANEOUS FAT; SWINE; THYROID GLAND; AGE; ANIMAL; ANIMAL EMBRYO; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; CLASSIFICATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYLOGENY; SEQUENCE HOMOLOGY;

AGE FACTORS; ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CLONING, MOLECULAR; EMBRYO, MAMMALIAN; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; MUSCLE, SKELETAL; ORGAN SPECIFICITY; PHYLOGENY; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, AMINO ACID; SWINE; THYROID GLAND;

EID: 84904997533     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.July.24.26     Document Type: Article

References (39)

1. Adams JM and Cory S (1998). The Bcl-2 protein family: arbiters of cell survival. Science281: 1322-1326.
2. Ball ST, Williamson CM, Hayes C, Hacker T, et al. (2001). The spatial and temporal expression pattern of Nesp and its antisense Nespas, in mid-gestation mouse embryos. Mech. Dev.100: 79-81.
3. Bastepe M (2008). The GNAS locus and pseudohypoparathyroidism. Adv. Exp. Med. Biol.626: 27-40.
4. Chen M, Haluzik M, Wolf NJ, Lorenzo J, et al. (2004). Increased insulin sensitivity in paternal Gnas knockout mice is associated with increased lipid clearance. Endocrinology145: 4094-4102.
5. Collins MT, Sarlis NJ, Merino MJ, Monroe J, et al. (2003). Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations. J. Clin. Endocrinol. Metab.88: 4413-4417.
6. Dorsett Y and Tuschl T (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov.3: 318-329.
7. Eisenhardt A, Scherag A, Jockel KH, Reis H, et al. (2011). Lack of association of the genotype in the GNAS Fok I polymorphism and prostate cancer. Urol. Int.87: 80-86.
8. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, et al. (1998). Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J. Clin. Endocrinol. Metab. 83: 2074-2078.
9. Happle R (1986). The McCune-Albright syndrome: a lethal gene surviving by mosaicism. Clin. Genet.29: 321-324.
10. Hart EA, Caccamo M, Harrow JL, Humphray SJ, et al. (2007). Lessons learned from the initial sequencing of the pig genome: comparative analysis of an 8-Mb region of pig chromosome 17. Genome Biol.8: R168.
11. Hayward BE, Barlier A, Korbonits M, Grossman AB, et al. (2001). Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest.107: R31-R36.
12. Hengartner MO (2000). The biochemistry of apoptosis. Nature407: 770-776.
13. Kalfa N, Lumbroso S, Boulle N, Guiter J, et al. (2006). Activating mutations of Gsalpha in kidney cancer. J. Urol.176: 891-895.
14. Kehlenbach RH, Matthey J and Huttner WB (1994). XL alpha s is a new type of G protein. Nature372: 804-809.
15. Kelsey G (2009). Epigenetics and imprinted genes: insights from the imprinted Gnas locus. Horm. Res.71 (Suppl 2): 22-29.
16. Kirk JM, Brain CE, Carson DJ, Hyde JC, et al. (1999). Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J. Pediatr.134: 789-792.
17. Kozasa T, Itoh H, Tsukamoto T and Kaziro Y (1988). Isolation and characterization of the human Gs alpha gene. Proc. Natl. Acad. Sci. U. S. A.85: 2081-2085.
18. Krechowec S and Plagge A (2008). Physiological dysfunctions associated with mutations of the imprinted Gnas locus. Physiology 23: 221-229.
19. Krumins AM and Barber R (1997). Examination of the effects of increasing Gs protein on beta2-adrenergic receptor, Gs, and adenylyl cyclase interactions. Biochem. Pharmacol.54: 61-72.
20. Kumar S (2007). Caspase function in programmed cell death. Cell Death. Differ.14: 32-43.
21. Landis CA, Masters SB, Spada A, Pace AM, et al. (1989). GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature340: 692-696.
22. Mantovani G, Lania AG and Spada A (2010). GNAS imprinting and pituitary tumors. Mol. Cell Endocrinol.326: 15-18.
23. Oczkowicz M, Piestrzynska-Kajtoch A, Ropka-Molik K, Rejduch B, et al. (2012). Expression and imprinting analysis of the NESP55 gene in pigs. Gene Expr. Patterns.12: 18-23.
24. Oldham WM and Hamm HE (2008). Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol.9: 60-71.
25. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, et al. (2008). Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur. J. Endocrinol.159: 623-631.
26. Pasolli HA, Klemke M, Kehlenbach RH, Wang Y, et al. (2000). Characterization of the extra-large G protein alpha-subunit XLalphas. I. Tissue distribution and subcellular localization. J. Biol. Chem.275: 33622-33632.
27. Patten JL, Johns DR, Valle D, Eil C, et al. (1990). Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N. Engl. J. Med.322: 1412-1419.
28. Plagge A, Kelsey G and Germain-Lee EL (2008). Physiological functions of the imprinted Gnas locus and its protein variants Galpha(s) and XLalpha(s) in human and mouse. J. Endocrinol.196: 193-214.
29. Reichmann E (2002). The biological role of the Fas/FasL system during tumor formation and progression. Semin. Cancer Biol.12: 309-315.
30. Schwindinger WF, Reese KJ, Lawler AM, Gearhart JD, et al. (1997). Targeted disruption of Gnas in embryonic stem cells. Endocrinology138: 4058-4063.
31. Snigdha S, Smith ED, Prieto GA and Cotman CW (2012). Caspase-3 activation as a bifurcation point between plasticity and cell death. Neurosci. Bull.28: 14-24.
32. Stewart CK, Li J and Golovan SP (2008). Adverse effects induced by short hairpin RNA expression in porcine fetal fibroblasts. Biochem. Biophys. Res. Commun.370: 113-117.
33. Stork PJ and Schmitt JM (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol.12: 258-266.
34. Taboada GF, Tabet AL, Naves LA, de Carvalho DP, et al. (2009). Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience. Pituitary12: 165-169.
35. Weinstein LS, Yu S, Warner DR and Liu J (2001). Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr. Rev.22: 675-705.
36. Weinstein LS, Liu J, Sakamoto A, Xie T, et al. (2004). Minireview: GNAS: normal and abnormal functions. Endocrinology 145: 5459-5464.
37. Weiss U, Ischia R, Eder S, Lovisetti-Scamihorn P, et al. (2000). Neuroendocrine secretory protein 55 (NESP55): alternative splicing onto transcripts of the GNAS gene and posttranslational processing of a maternally expressed protein. Neuroendocrinology71: 177-186.
38. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P, et al. (1995). G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur. J. Clin. Invest.25: 128-131.
39. Wilson CH, McIntyre RE, Arends MJ and Adams DJ (2010). The activating mutation R201C in GNAS promotes intestinal tumourigenesis in Apc(Min/+) mice through activation of Wnt and ERK1/2 MAPK pathways. Oncogene 29: 4567-4575.